End Stage Renal Disease Enas S. Nimri, D.D.S. - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

End Stage Renal Disease Enas S. Nimri, D.D.S.

Description:

... dialysis or kidney transplantation, death will occur from accumulation of ... Hypertension, congestive heart failure, urinary tract infections, kidney stones, ... – PowerPoint PPT presentation

Number of Views:582
Avg rating:3.0/5.0
Slides: 31
Provided by: dbUt
Category:

less

Transcript and Presenter's Notes

Title: End Stage Renal Disease Enas S. Nimri, D.D.S.


1
End Stage Renal DiseaseEnas S. Nimri, D.D.S.
2
The Kidney
  • The kidneys are responsible for removing
    wastes from the body, regulating electrolyte
    balance and blood pressure, converting Vit D into
    its active form, and stimulating rbc production
    by synthesizing erythropoietin.

3
Nephron
The nephron is the functional unit of the kidney
4
What is ESRD?
  • The deterioration of nephrons resulting in loss
    of ability to excrete wastes, concentrate urine,
    and regulate electrolytes.
  • Occurs as chronic or acute renal failure
    progressing to the point where function is less
    than 10 of normal. Function is so low that
    without dialysis or kidney transplantation, death
    will occur from accumulation of fluids and waste
    products in the body.
  • ESRD almost always follows chronic kidney
    failure, which may exist for 10 - 20 years or
    more before progression to ESRD.

5
Incidence/Prevalence
  • - More than 20 million people in the US
    have chronic kidney disease
  • - More than 345,000 people suffer from
    ESRD
  • - 31 of cases annually occurs in African
    Americans
  • - 2 of cases of ESRD each year occurs in
    native Americans
  • - 31 of cases of ESRD each year occurs
    in Caucasians in America
  • - 60,000 people die annually

6
Causes
Hypertension
Chronic Glomerulonephritis
Congestive Heart Failure
Diabetes (most common cause)
7
Causes
Systemic Lupus Erythrematosus
Polycystic Kidney Disease
Amyloidosis
Atherosclerosis
8
Causes
Aminoglycoside nephrotoxicity (Gentamycin,
Azithromycin)
IV contrast medium
Long term use of NSAIDS
9
Causes
Nephrolithiasis
Prostate Cancer
10
Symptoms
Unintentional weight loss Nausea or
vomiting Fatigue Headache Generalized itching
Greatly decreased urine output No urine
output Easy bruising or bleeding May have blood
in the vomit or stools Decreased alertness
drowsiness, somnolence, lethargy confusion,
delirium coma Muscle twitching or cramps
Seizures Increased skin pigmentation Skin may
appear yellow or brown Nail abnormalities
Decreased sensation in the hands, feet, or other
areas
11
Complications
  • Pericarditis, cardiac tamponade, CHF, HTN, edema
  • Platelet dysfunction, anemia
  • Renal encephalopathy, dementia, seizures,
    peripheral neuropathy
  • Hyperparathyroidism, osteoporosis, osteomalacia
  • Decreased immune response, increased incidence of
    infection
  • Hepatitis C, Hepatitis B, liver failure
  • Electrolyte imbalances hyperkalemia,
    hyponatremia, hypocalcemia

12
Lab Tests
  • Creatinine and BUN levels (chronically high)
  • Creatinine clearance (very low).
  • Electrolyte measurements (high K, low Na)
  • Urinalysis

13
Creatinine
  • Creatinine is a breakdown product of creatine, an
    important part of muscle.
  • Creatinine is excreted entirely by the kidneys.
  • With kidney failure, the serum creatinine level
    is high.
  • Normal value 0.8 to 1.4 mg/dl.

14
BUN (Blood Urea Nitrogen)
  • Measures the amount of urea nitrogen (a breakdown
    product of protein metabolism) in the blood.
  • Urea is formed in the liver as the end product of
    protein metabolism.
  • The urea makes its way into the blood and it is
    ultimately eliminated in the urine by the
    kidneys.
  • With kidney failure BUN levels are chronically
    high.
  • Normal Value 7 to 20 mg/dl

15
Creatinine Clearance
  • Creatinine clearance estimates glomerular
    filtration rate (the volume of filtrate made by
    the kidneys per minute). Urine and serum
    creatinine levels are measured along with the
    urine volume in 24 hours. Clearance rate is then
    calculated.
  • With kidney failure clearance is chronically low.
  • Normal values
  • Male 97 to 137 ml/min. Female 88 to
    128 ml/min.

16
Treatment
  • Diseases that cause or result from chronic renal
    failure must be controlled. Hypertension,
    congestive heart failure, urinary tract
    infections, kidney stones, obstructions of the
    urinary tract, glomerulonephritis, and other
    disorders should be treated appropriately
  • Dialysis or kidney transplantation are the only
    treatments for ESRD
  • In the U.S., nearly 300,000 people are
    on long-term dialysis and more than 20,000 have a
    functioning transplanted kidney.

17
Dialysis Method of removing toxic substances
from the blood.Blood is diverted from the access
through a filter. The blood flows counter-current
to a special solution called the dialysate. The
electrolyte imbalances and toxins in the blood
are corrected and the is returned to the body.
Peritoneal
Hemodialysis
18
Peritoneal
  • Works by using the body's peritoneal membrane,
    inside the abdomen, as a semi-permeable membrane.
    Solutions that help remove toxins are infused in,
    remain in the abdomen for a certain time period,
    and are eventually drained out. This can be done
    at home on a continuous basis.
  • Indicated in patients with acute renal failure,
    require occasional dialysis, or those who are
    young and have the capability of doing this at
    home.

19
Hemodialysis
  • Works by circulating the blood, from an access in
    the body, through a semi-permeable filter in the
    dialysis machine that helps remove toxins. The
    cleansed blood is then returned to the body.
  • Typically, most patients undergo hemodialysis for
    three sessions every week. Each session lasts 3-4
    hours
  • Patients on hemodialysis are always heparinized
    to prevent clotting of the AV access.
  • Indicated in chronic tx and obese patients

20
Catheters
Subclavian
  • Catheters are a form of temporary access.
    Large-bore catheters placed in large veins that
    can support acceptable blood flows. Most
    catheters are used in emergency situations, for
    short periods of time. However, catheters called
    tunneled catheters can be used for prolonged
    periods of time, often weeks to months.

Femoral
21
Arterio-Venous Connections
  • Permanent access is created by surgically joining
    an artery to a vein. This allows the vein to
    receive blood at high pressure, leading to
    thickening of the vein's wall. The "arterialized
    vein" can sustain repeated puncture and provides
    excellent blood flow rates. The connection
    between an artery and a vein can be made using
    blood vessels (an arteriovenous fistula, or AVF)
    or a synthetic bridge (arteriovenous graft, or
    AVG).

22
Arterio-Venous Fistula (AVF)
  • The AVF is desirable, because rates of infection
    are very low and it is durable. It may take many
    months for the AVF to mature, so careful planning
    is required.

23
Arterio-Venous Graft
  • The AVG can be accessed a few weeks after
    grafting. It provides good flows but has a high
    complication rate. It should be attempted only if
    the AVF is not feasible.

24
Oral Complications
  • Pallor of oral mucosa secondary to anemia.
  • Xerostomia due to medications
  • Metallic taste and saliva may have characteristic
    ammonia-like odor due to high urea content.
  • In severe renal failure, stomatitis may be
    present.
  • Excessive postoperative bleeding
  • Radiographic changes due to secondary
    hyperparathyroidism
  • loss of lamina dura
    demineralized bone
  • ground glass appearance

25
Dental Considerations for all ESRD patients
  • Physician should be consulted. Decide on
    treatment setting (inpatient vs. outpatient).
    If ESRD is well-controlled, generally no problem
    in providing outpatient care.
  • Monitor blood pressure in arm without shunt
  • Use good surgical technique to minimize bleeding
  • Antibiotic prophylaxis if needed
  • Modify drug selection and drug dosage
  • Universal infection control
  • Obtain pretreatment lab values for bleeding time
    (BT), platelet count, hematocrit, hemoglobin, CBC
    with differential, INR,PT,PTT

26
Normal Lab Values
27
Dental Considerations for Patients on Dialysis
  • AVF is susceptible to infection (endarteritis)
    due to dental bacteremia and can cause
    endocarditis. Physician and dentist must
    determine whether or not to administer
    prophylactic antibiotics.
  • Avoid dental treatment on day of dialysis due to
    possibility of excessive bleeding. Best time for
    dental treatment is the DAY AFTER hemodialysis.

28
Dental Considerations for Transplant Patients
  • Pretransplant eliminate all source of infection
  • eliminate active dental
    disease
  • aggressive OH regimen
  • Postransplant Emergency tx only for 1st
  • 6 months
  • Immunosuppressed pt
    requires supplemental
    corticosteroids

29
Drug Interactions
  • Drugs primarily excreted by the kidney or that
    are nephrotoxic Tetracycline, Acyclovir,
    Acetaminophen, ASA, NSAlDS, Vancomycin, and
    Gentamycin.
  • Certain drugs are removed during hemodialysis and
    require additional dose to be given after
    hemodialysis.

30
References
  • Medline
  • Little JW, Falace DA. Dental Management of the
    Medically Compromised Patient. 4th ed. St Louis,
    MO Mosby Year Book, Inc 1993 248-257.
  • Naylor GD, Fredericks MR. Pharmacologic
    considerations in the dental management of the
    patient with disorders of the renal system.Dent
    Clin North Am. 1996 Jul40(3)665-83.
  • El Mouedden et al., Tox. Sci. (2000) 56229-239.
  • www.lxi.leeds.ac.uk/.../rsna00/subtraction.htm
Write a Comment
User Comments (0)
About PowerShow.com